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Patients with psychosis display structural brain abnormalities in multiple brain regions.
The disorder is characterized by a putative prodromal period called ultra-high-risk (UHR)
status, which precedes the onset of full-blown psychotic symptoms. Recent studies on
psychosis have focused on this period. Neuroimaging studies of UHR individuals for psy-
chosis have revealed that the structural brain changes observed during the established
phases of the disorder are already evident prior to the onset of the illness. Moreover, cer-
tain brain regions show extremely dynamic changes during the transition to psychosis.
These neurobiological features may be used as prognostic and predictive biomarkers for
psychosis. With advances in neuroimaging techniques, neuroimaging studies focusing on
gray matter abnormalities provide new insights into the pathophysiology of psychosis, as
well as new treatment strategies. Some of these novel approaches involve antioxidants
administration, because it is suggested that this treatment may delay the progression of
UHR to a full-blown psychosis and prevent progressive structural changes. The present
review includes an update on the most recent developments in early intervention strate-
gies for psychosis and potential therapeutic treatments for schizophrenia. First, we provide
the basic knowledge of the brain regions associated with structural abnormalities in indi-
viduals at UHR. Next, we discuss the feasibility on the use of magnetic resonance imaging
(MRI)-biomarkers in clinical practice. Then, we describe potential etiopathological mecha-
nisms underlying structural brain abnormalities in prodromal psychosis. Finally, we discuss
the potentials and limitations related to neuroimaging studies in individuals at UHR.
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INTRODUCTION
Schizophrenia is the most disabling psychotic illness that affects
approximately 1% of individuals worldwide. The disorder is
characterized by a prodromal period that precedes the onset of
full-blown psychotic symptoms, showing abnormalities in social-
ization and thinking (Yung and McGorry, 1996). Recent studies
on psychosis have focused on the early course of the disor-
der (McGorry et al., 2008). The ultimate goal of researchers
is to determine vulnerability- and disease-specific biological
markers in an effort to predict the onset or course of the
illness.
Over the past three decades, multiple neuroimaging studies
have revealed brain abnormalities in patients with psychotic dis-
orders. The notion that brain abnormalities contribute to the eti-
ology of psychosis was initially proposed by Kraepelin (1919/1971)
and Bleuler (1950) more than 110 years ago. This concept,however,
was largely discredited during the twentieth century. A renewed
interest in psychosis was generated after the first CT study by
Johnstone et al. (1976). The first magnetic resonance imaging
(MRI) study in patients with schizophrenia was published by
Smith et al. (1984). Since then, the investigation of brain struc-
ture abnormalities associated with psychosis has flourished. MRI
is the most established and used technique of for the investiga-
tion of the human brain structure in vivo. Over the past 27 years,
MRI studies in patients with psychosis have played a pivotal role
in providing support for the argument that brain abnormalities
are associated with the disease. Moreover, this period has offered
tremendous knowledge about the neurobiological basis of psy-
chosis. Patients with psychosis have been shown to have enlarged
lateral ventricles and reduced volume in the hippocampus, supe-
rior temporal gyrus (STG), and prefrontal cortices (PFC; Shenton
et al., 2001; MacDonald and Schulz, 2009). Some discussion how-
ever was raised regarding the potential confounding role played by
illness duration and antipsychotic treatment. Interestingly, some
of these structural abnormalities are also observed in first-episode
patients (FEP; Steen et al., 2006) who have a short duration of ill-
ness and a minimal exposure to antipsychotic treatment. Recently,
new approaches that study individuals at high-risk for the disease
have been used to better circumvent these problems and address
this issue.
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Specifically, two approaches focusing on high-risk subjects have
been used to elucidate vulnerability to psychosis and minimiz-
ing confounding variables including neurodegenerative progress
of the disease, institutionalization, and long-term treatment with
antipsychotic medication. The genetic-high-risk (GHR) approach
focuses on non-psychotic first-degree relatives of patients with
schizophrenia, exploring trait markers of genetic vulnerability
for the disorder, called endophenotypes. Alternatively, the clini-
cal high-risk [CHR; also called ultra-high-risk (UHR), or at risk
mental state (ARMS)] strategy focuses on individuals presenting
with subthresholded psychotic features: (i) attenuated psychotic
symptoms (APS), (ii) brief limited intermitted psychotic symp-
toms (BLIPS), and (iii) trait-plus-state risk factors [i.e., recent
decline in social functioning and genetic risk for psychosis, genetic
risk and deterioration syndrome (GRD; Yung et al., 2003]. Histor-
ically, the development of UHR criteria was introduced by Yung
and McGorry, 1996; for a comprehensive state-of-the-art review
on the high-risk state see, Fusar-Poli et al., 2012a). Research in the
UHR field has progressed to the point that a new UHR diagnostic
category is being considered for introduction in the forthcom-
ing DSM-5 (Fusar-Poli and Yung, 2012). A recent meta-analysis
in over than 2500 CHR subjects has showed that there is a con-
sistent transition risk across different diagnostic criteria ranging
from 18% at 6 months up to 36% after 3 years (Fusar-Poli et al.,
2012b). The majority (73%) of these high-risk subject who will
later transit to psychosis will develop a schizophrenic psychosis as
compared to affective psychoses (11%, risk ratio 5.44; Fusar-Poli
et al., 2012c). The high-risk state for psychosis is also associated
with impaired quality of life and subtle impairments in cognitive
functioning (Fusar-Poli et al., 2012d). In this scenario, neurobio-
logical markers of liability to psychosis and transition to full illness
can augment the predictive validity of current psychopathologi-
cally based criteria (Fusar-Poli and Broome, 2006; McGuire et al.,
2008). To address this issue, neuroimaging studies of UHR patients
may describe neurobiological markers of illness state as well as trait
markers. However, despite the large number of structural imag-
ing investigations in established psychosis and in UHR subjects,
clinical applications for psychiatric neuroimaging are still lacking
(Kloppel et al., 2012).
In the present review, recent MRI findings of UHR patients
are critically reviewed along with multiple structural brain mea-
sures (regional brain volume and cortical thickness) suggesting
that gray matter volume (GMV) abnormalities are associated with
the onset of psychosis. Therefore, this review focuses on studies
of MRI changes in UHR patients. The MRI studies discussed in
this review are selected on a critical review of the available lit-
erature and they are listed in Table 1. The present article is not
intended as a thorough review of all structural MRI studies in
UHR patients [Wood et al., 2008; Pantelis et al., 2009; Jung et al.,
2010; Smieskova et al., 2010; Borgwardt et al., 2011; Fusar-Poli
et al., 2011a; Gogtay et al., 2011; for meta-analyses of structural
findings in subjects at high clinical risk for psychosis (see Fusar-
Poli et al., 2011b, 2012f) in subjects at genetic risk for psychosis
(see Fusar-Poli et al., 2012e) for functional meta-analyses in sub-
jects at clinical risk for psychosis (see Fusar-Poli et al., 2007;
Fusar-Poli and Meyer-Lindenberg, 2012a,b)]. Rather, this review
(i) provides basic knowledge of the brain regions associated with
structural abnormalities in UHR patients; (ii) focuses on the use
of MRI-biomarkers in clinical practice; (iii) suggests potential
etiopathological mechanisms underlying structural brain abnor-
malities in prodromal psychosis; and (iv) discusses the potentials
and limitations related to neuroimaging studies in individuals
at UHR.
GM ABNORMALITIES IN INDIVIDUALS AT UHR
CROSS-SECTIONAL COMPARISON BETWEEN INDIVIDUALS AT UHR
AND HEALTHY CONTROLS
Magnetic resonance imaging studies of patients with established
psychosis have revealed brain structural abnormalities associated
with the disorder. Individuals at UHR, however, may demon-
strate some specific markers of potential vulnerability to psychosis.
Accumulating data has revealed that neurobiological abnormali-
ties in UHR subjects are qualitatively similar to but less severe than
are those in patients with established psychosis.
Previous studies employing region of interest (ROI) or whole-
brain voxel-based morphometric (VBM) methods have reported
reduced hippocampal GMV in UHR individuals compared with
healthy controls (Phillips et al., 2002; Wood et al., 2005, 2010; Borg-
wardt et al., 2007a; Hurlemann et al., 2008; Buehlmann et al., 2010;
Witthaus et al., 2010), although results have been inconsistent
(Velakoulis et al., 2006). Studies have shown that UHR individ-
uals displayed deficits in hippocampal-associated verbal memory
(Hurlemann et al., 2008). Wood et al. (2005) reported decreased
hippocampal volume in UHR patients without a family history
of psychosis compared with individuals with a family history of
psychosis, suggesting that non-specific environmental factors are
more highly associated with morphological abnormalities than are
genetic factors.
Prefrontal cortex abnormalities in UHR patients have been
reported in the lateral PFC (Meisenzahl et al., 2008; Koutsouleris
et al., 2009a; Witthaus et al., 2009), medial PFC, and ACC (Borg-
wardt et al., 2007a; Witthaus et al., 2009; Jung et al., 2011; Choi
et al., 2012). Moreover, using VBM and functional MRI (fMRI)
techniques, reduced GMV in the middle frontal gyrus was cor-
related with reduced neural activity in this region (Fusar-Poli
et al., 2011c). Deficits in the ACC may provide evidence of early
neurodevelopmental anomalies in schizophrenia, as reports have
indicated alterations in the pattern of cortical folding in this
region (Yücel et al., 2003). Altered cortical folding patterns in
UHR individuals without a family history of psychosis, compared
with individuals with a family history, suggested involvement of
environmental rather than genetic factors (Wood et al., 2005).
Specifically, abnormalities in the midline cortical structures (i.e.,
medial PFC and ACC) in UHR patients may contribute to their
disrupted sense of self (Nelson et al., 2009). Recently, UHR individ-
uals were shown to have aberrant connectivity in the default mode
network, which is involved in self-referential processing (Shim
et al., 2010). Reduced GMV in the parietal area in UHR patients
was also observed (Fusar-Poli et al., 2011d), and cortical thinning
in the parietal regions in UHR patients was reported (Jung et al.,
2011). However, Haller et al. (2009) reported no differences in cor-
tical thickness, but did find differences in cortical asymmetry in
the parietal, insular, and occipitotemporal gyri between UHR indi-
viduals and controls. A recent magnetoencephalography (MEG)
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study in UHR patients showed aberrant alpha modulation related
to selective attention, particularly in the parieto-occipital region
(Koh et al., 2011). A multimodal EEG-MRI study reported a rela-
tionship between P300 amplitude and GMV in the supramarginal
gyrus in UHR patients (Fusar-Poli et al., 2011d).
Volumetric abnormalities in the lateral temporal lobe, partic-
ularly the STG, in UHR patients have frequently been reported.
The STG processes sounds and social information and is related to
functional deficits, including auditory hallucinations and thought
disorders (Allen, 2008; Sun et al., 2009b). Several ROI and VBM
studies in UHR patients have reported reduced STG volume (Borg-
wardt et al., 2007a; Koutsouleris et al., 2009a; Witthaus et al., 2009;
Takahashi et al., 2010), although these findings are inconsistent
(Takahashi et al., 2009a). Recent studies of surface-based corti-
cal thickness were consistent with previous findings and indicated
reduced STG volume in UHR patients (Jung et al., 2011). MEG
studies have identified aberrant auditory processing in UHR indi-
viduals, including defects in N1m adaptation, the magnetic coun-
terpart of MMN (MMNm), and correlations between MMNm
and clinical symptoms (Shin et al., 2009, 2012).
Aberrant GMV in limbic system regions such as the insula
and amygdala has also been reported. UHR individuals showed
reduced insular volume (Borgwardt et al., 2007a,b; Takahashi et al.,
2009b) but no differences in amygdala volume (Velakoulis et al.,
2006; Witthaus et al., 2009). A recent study investigated the volume
of the caudate nuclei using ROI techniques (Hannan et al., 2010).
Caudate nuclei volumes did not differ significantly between UHR
individuals and healthy controls.
Given that the medial PFC, ACC, inferior frontal gyrus, insula,
and STG are involved in social cognitive processes (Blakemore,
2008), UHR individuals may display abnormal social function-
ing. There is significant evidence to support this hypothesis [i.e.,
impaired social functioning (Shim et al., 2008) and social cogni-
tion (Chung et al., 2008)]. Patients with psychosis have alterations
in facial processing (Shin et al., 2008). Interestingly, UHR indi-
viduals also display similar deficits (Kim et al., 2010), suggesting a
role for social dysfunction in psychosis.
CROSS-SECTIONAL COMPARISON BETWEEN INDIVIDUALS AT UHR-P
AND UHR-NP
Individuals at UHR are a heterogeneous group that includes indi-
viduals who later develop psychosis (UHR-P) and those who do
not (UHR-NP). Some brain abnormalities may reflect an under-
lying vulnerability for psychosis, whereas others may be associated
with progression due to an acute illness. Therefore, differences in
GMV between individuals at UHR-P and UHR-NP are of specific
interest.
In ROI studies, individuals at UHR-P displayed smaller insu-
lar (Takahashi et al., 2009b) and hippocampal GMV (Wood et al.,
2010) and increased pituitary volume (Garner et al., 2005). Phillips
et al. (2002) reported greater hippocampal volume in UHR-P
patients compared with UHR-NP patients and FEP. No GMV dif-
ferences were noted between UHR-P and UHR-NP in several brain
regions including the STG (Takahashi et al., 2010), hippocampus
(Buehlmann et al., 2010), amygdala (Velakoulis et al., 2006), cau-
date nucleus (Hannan et al., 2010), or in ACC cortical folding
patterns (Yücel et al., 2003). However, the caudate nucleus volume
in UHR-P patients was positively correlated with total errors in
spatial working memory and verbal fluency performance (Hannan
et al., 2010). In VBM studies, UHR-P patients displayed smaller
GMV in the insula and in the ACC compared with UHR-NP
patients (Pantelis et al., 2003; Borgwardt et al., 2007a). Borg-
wardt et al. (2007b) found no differences in these two regions
between individuals at UHR-P and FEP. Reductions in the PFC
and orbitofrontal cortex, however, were noted (Koutsouleris et al.,
2009a; Dazzan et al., 2012). Fornito et al. (2008) assessed cortical
thickness in the ACC in UHR patients and found that UHR-P indi-
viduals showed cortical thinning in the rostral paralimbic region. A
recent study reported decreased cortical thickness in the ACC,PFC,
STG, and inferior temporal cortex in UHR-P individuals (Jung
et al., 2011). Moreover, UHR-P individuals displayed poor social
cognition (Kim et al., 2011) and social functioning compared with
UHR-NP individuals (Jang et al., 2011).
LONGITUDINAL COMPARISON
Longitudinal studies have focused on the pathophysiological
nature of brain abnormalities around the time of the onset of
illness. Using the VBM approach, Pantelis et al. (2003) reported
that UHR-P patients displayed longitudinal reductions in the
orbitofrontal, cerebellar, fusiform, and parahippocampal cortices
and the cingulate gyrus. Borgwardt et al. (2008) reported progres-
sive volume reductions in the orbitofrontal cortex and cerebellum,
as well as the superior frontal, inferior temporal, and superior pari-
etal cortices and the precuneus. ROI studies have found greater
reductions in the insula (Takahashi et al., 2009b) and STG (Taka-
hashi et al., 2009a) in UHR-P patients compared with patients at
UHR-NP. Using cortical pattern matching techniques, Sun et al.
(2009a) revealed greater brain contraction in the PFC in UHR-
P patients compared with that in UHR-NP patients. A recent
surface-based cortical thickness study found that UHR-P indi-
viduals displayed cortical thinning in widespread regions in the
ACC, precuneus, and temporo–parieto–occipital areas (Ziermans
et al., 2012). Recent longitudinal multimodal studies have used
MRI with other neuroimaging modalities. A longitudinal elec-
troencephalogram (EEG)-VBM study reported progressive GM
alterations in the PFC and subcortical areas, including the cau-
date, in patients at UHR, but no significant changes over time
in the P300 amplitude during a task (Fusar-Poli et al., 2011d).
UHR-P patients showed reduced GMV in the middle temporal
gyrus, and UHR-NP patients showed decreased GMV in the supe-
rior frontal gyrus, caudate, and putamen between a baseline and
follow-up session. In contrast, no significant differences in GMV
were noted between the baseline and the follow-up scan in UHR
patients in another longitudinal fMRI-VBM study from the same
center (Fusar-Poli et al., 2011c). However, longitudinal increases
in activation in the parahippocampus and ACC were noted. Taken
together, these findings suggest that GMV abnormalities in some
brain regions dynamically emerge during the acute process of tran-
sition to psychosis, particularly showing progressive changes in the
frontal and temporal regions in UHR-P patients.
VOXEL-WISE META-ANALYSES AND MULTICENTER STUDIES
There is accumulating evidence for structural changes in
UHR individuals. Moreover, researchers have recently conducted
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voxel-wise meta-analysis studies in UHR patients (Smieskova et al.,
2010; Fusar-Poli et al., 2011b, 2012f). Smieskova et al. (2010)
reported decreased PFC, cingulate, insula, and cerebellar GMV
in UHR-P patients compared with UHR-NP patients. Method-
ological differences and different high-risk statuses (i.e., GHR,
UHR) were noted between the studies. However, changes in the
PFC, ACC, medial temporal, and cerebellar cortex may predict the
development of psychosis in UHR patients. To address the het-
erogeneity across studies that use different methods, Fusar-Poli
et al. (2011b) conducted a voxel-wise meta-analysis of whole-
brain VBM studies in high-risk individuals including UHR or
GHR. UHR patients compared with healthy controls displayed
reduced GMV in the STG, parahippocampal region, precuneus,
medial and middle frontal gyri, and the ACC. Compared with
UHR-NP patients, UHR-P patients showed baseline GM reduc-
tions in the inferior frontal gyrus and the STG. UHR individuals
relative to GHR displayed greater volume in the parahippocampal
gyrus, insula, and STG and less volume in the ACC. Additionally,
the study confirmed significant effects of atypical antipsychotic
treatment on the inferior frontal gyrus and insula. To remove con-
founding effects of antipsychotic drugs, Fusar-Poli et al. (2012f)
conducted an additional voxel-wise meta-analysis on VBM stud-
ies enrolling antipsychotic-naïve subjects. GMV reductions were
found in the middle and superior temporal gyri, hippocampal
regions, and middle frontal gyrus in patients at UHR, and in the
STG, insula, and cerebellum in FEP patients. Compared with UHR
subjects, FEP subjects showed GM decreases in the STG, ACC,
insula, and cerebellum. Moreover, an inverse correlation was noted
between STG GMV and symptom severity, suggesting that the STG
is associated with the onset of psychotic symptoms.
A multicenter study conducted on UHR patients collected data
from five sites (subjects were 167 healthy controls, 48 UHR-P, 134
UHR-NP) and was recently published (Mechelli et al., 2011). The
UHR group had less GMV in the frontal regions compared with
controls. Compared with patients with UHR-NP, UHR-P patients
had less GMV in the parahippocampal cortex.
THE FEASIBILITY OF NEUROANATOMICAL BIOMARKERS
Despite the convincing evidence from neuroimaging studies, the
feasibility of using MRI-based data on structural changes remains
far in the future for clinical practice in psychiatry. This is largely
due to the overlap with anatomical variation within the nor-
mal range. Recently, advancements in computer visualization and
neuroimaging techniques have raised intense interest in diagnos-
tic MRI-based biomarkers. Particularly, multivariate classification
approaches for pattern recognition of whole-brain data (i.e., sup-
port vector machine, SVM) are becoming increasingly popular
in situations in which changes do not affect a single location
but are expressed in a distinct pattern across the brain. Using
advanced pattern recognition methods, Koutsouleris et al. (2009b)
attempted to develop potential MRI-based biomarkers for the pre-
diction of illness outcomes that are reliable and feasible in clinical
practice. They convincingly demonstrated extensive GM distrib-
ution differences in various categories in individuals at risk for
psychosis and morphological pattern differences between individ-
uals at UHR-P and those at UHR-NP. The findings from this study
have been replicated in independent populations (Koutsouleris
et al., 2012). The expression of progressive dynamic changes in
GMV during illness transition has been predicted using neu-
roanatomical pattern regression (i.e., support vector regression,
SVR; Koutsouleris et al., 2010a).
Although the aforementioned studies showed the potential for
early recognition and disease prediction in patients at UHR, it
is unclear whether MRI-based biomarkers could generalize to
clinical practice. There are some unresolved questions regarding
the generalization of biomarkers (Kloppel et al., 2012). Given
the high classification accuracy from the multivariate pattern
recognition approach and the view that schizophrenia is a dis-
order of large-scale neurocognitive networks rather than specific
regions (Menon, 2011), we suggest that neuroanatomical mark-
ers for psychosis may be associated with distinct coordinated
patterns of cortical morphology rather than with abnormali-
ties in specific regions per se. In this sense, the concepts of
graph theory (He et al., 2008) and hyper-networks (Ha et al.,
2009) may be applied to quantitatively characterize these com-
plex anatomical patterns. Future studies should address issues
of clinical and genetic heterogeneity between patients, includ-
ing differences in symptoms, duration, medication, and genetic
vulnerability, which may influence neurobiological substrates in
a complex way. The human brain is not static, but dynamically
changes throughout life. MRI-biomarkers for psychosis are also
not static and may therefore indicate the magnitude of change
over time.
POTENTIAL ETIOPATHOLOGICAL MECHANISMS FOR GM
ABNORMALITIES AND THERAPEUTIC IMPLICATIONS
The underlying basis of GM abnormalities is currently unknown;
however, alterations in brain processes involved in the pathology of
psychosis may contribute to the structural abnormalities. Struc-
tural brain alterations in the fronto-temporal regions observed
in patients with psychosis occur before the onset of full-blown
psychosis. These regions are the same regions where lesions in ani-
mals result in striatal dopaminergic abnormalities (Flores et al.,
1996; Lodge and Grace, 2007; Howes and Kapur, 2009). Striatal
hyperdopaminergia has been postulated to be fundamental to
the emergence of the psychotic symptoms (Kapur et al., 2005).
Recent studies indicate that elevated striatal dopamine function
predates the onset of psychosis in UHR subjects (Howes et al.,
2009; Fusar-Poli et al., 2010a). It is thus conceived that striatal
dopaminergic elevation is present in a compromised brain in psy-
chosis and GM alterations may be associated with dopaminergic
subcortical alterations (Howes and Kapur, 2009).
Based on findings from post-mortem studies, GMV alterations
may be due to changes in neuronal, synaptic, and dendritic density,
as well as increased afferentation in certain regions (Fornito et al.,
2009). The combined volume of synapses, axons, and dendrites
make up approximately 70% of the total GMV (Chklovskii et al.,
2002; Fingerman et al., 2010). Abnormalities in specific region
may result from different causes in different individuals (Fornito
et al., 2009). Therefore, differences in developmental trajectories
may result in significant differences between patients and controls
(Fingerman et al., 2010). Recent works by Fornito et al. (2009)
have helped to bridge the gap between neuroimaging and the neu-
ropathology of schizophrenia, particularly in the ACC. Differences
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in cortical GMV may be due to differences in the neuropil (Sow-
ell et al., 2003), where the synaptic connections between branches
of axons and dendrites are formed. Therefore, excessive synap-
tic pruning during adolescence may contribute to the structural
changes. However, the effects of synapse loss are less than the differ-
ences in GMV observed between patients and controls, as synaptic
boutons constitute approximately 10% of GMV (Chklovskii et al.,
2002; Fingerman et al., 2010). One-third of the signal in T1-imaged
cortex is from white matter (Paus, 2005); therefore, myelination of
excess connections (increased afferentation) during adolescence
and early adulthood may contribute to the reductions in GMV
observed on MRI (Benes et al., 1987). Any alterations in apop-
totic mechanisms associated with cell death may also contribute
to differences in GMV.
Therefore, it may be valuable to discuss the causes of aber-
rant apoptotic mechanisms in relation to contemporary theories
of psychosis. Note that the following suggestions are purely spec-
ulative. One possibility is the involvement of immune and inflam-
matory mechanisms, which directly affect neuronal proliferation,
differentiation, migration, and apoptosis (Ader, 2007). It has been
hypothesized that viruses could directly damage brain structures,
or a virus may come in contact with the fetal brain and induce
a dysfunctional reaction in the immature immune system, lead-
ing to autoimmune pathology (Kirch, 1993). Among antibodies
against neurotropic viruses, studies have focused on the family of
herpes viruses. Exposures to herpes simplex virus type 1 (HSV1)
in patients with UHR was associated with structural abnormali-
ties in the cuneus, which is consistent with the region found in
HSV1-infected patients with established schizophrenia (Whitford
et al., 2012).
Another possibility is the experience of psychological stress
around the time of illness onset (Lodge and Grace, 2011). Gen-
erally, one biological system proposed as the link between the
psychological experience of stress and the development of psy-
chosis is the hypothalamic–pituitary–adrenal (HPA) axis (Phillips
et al., 2006). Garner et al. (2005) examined pituitary volume as
an indirect measure of HPA-axis dysfunction and found a larger
pituitary volume in UHR-P compared with UHR-NP patients.
Thompson et al. (2007) found that compared with UHR-NP,
UHR-P patients displayed lower plasma cortisol levels at base-
line, although there was no correlation between these levels and
stressful events, suggesting that HPA-axis dysfunction is involved
in the development of psychosis.
Recent studies have suggested the role of stress in GMV alter-
ations in corticostriatal-limbic regions associated with emotional
regulation and cognitive control. This is consistent with studies
in individuals at UHR, suggesting that these changes may serve to
mediate vulnerability to later psychopathology. A significant rela-
tionship between cumulative adversity/stress and smaller GMV
in the medial PFC, ACC, and insula was found in adults (Ansell
et al., 2012). Exposure to childhood maltreatment was associ-
ated with reduction in corticostriatal-limbic GM (Edmiston et al.,
2011). Moreover, the results of preliminary analyses showed dif-
ferent regional patterns of decreases in GM between males and
females; females showed GM reductions in regions associated with
emotional regulation, whereas males showed GM reductions in
regions involved in impulse control. The authors speculated that
vulnerabilities to mental illness in adolescence may be moderated
by gender. These sexually dimorphic developmental trajectories
are associated with sex hormones and may contribute to sex dif-
ferences in psychiatric disorders. Pubertal hormones play a role
in brain development during the transition from childhood to
adolescence, including structural brain-circuit remodeling, myeli-
nation, neural pruning, apoptosis, and dendritic spine remodeling
(Vigil et al., 2011). Indeed, estrogen has neuroprotective effects
on the brain (Norbury et al., 2003). For example, it acts against
several toxins that boost the production of free radicals (Simp-
kins et al., 1994) and may itself act as an antioxidant to protect
membranes against reactive oxygen species (ROS) as byproducts
of oxygen metabolism (Behl et al., 1995). There is a high con-
sumption of oxygen and enrichment of polyunsaturated fatty
acids (PUFAs) in the neuronal membrane. Therefore, the brain
is highly susceptible to oxidative damage from free radical attack,
called lipid peroxidation. Oxidative stress due to an excess of
ROS or a decrease in antioxidant levels results in brain damage
and can lead to neurodegenerative diseases. Estrogen may play a
role as an antioxidant. Estrogen also modulates the neurochem-
ical transmitter systems, including the serotonergic, cholinergic,
noradrenergic, and dopaminergic systems (Norbury et al., 2003).
These neurotransmitter systems are associated with the symptoms
of schizophrenia. The effects of estrogen on neurotransmitters may
partially explain why late-onset schizophrenia is more common in
post-menopausal women (i.e., decline in levels of estrogen) and
the disorder presents earlier in men than in women. This concept
is known as the estrogen-protection hypothesis of schizophre-
nia (Riecher-Rossler and Kulkarni, 2011). Kulkarni et al. (2012)
recently reviewed this hypothesis and suggested that estrogen may
offer a novel therapeutic strategy. Alternatively, the testosterone-
protection hypothesis states that testosterone protects against
schizophrenia by modulating the neurotransmitters implicated
in the disorder (Duggal et al., 2002). Testosterone also plays a
neuroprotective role in the brain (Hammond et al., 2001), and
lower testosterone in patients with schizophrenia was associated
with a greater number of negative symptoms (Akhondzadeh et al.,
2006). van Rijn et al. (2011) recently investigated levels of sali-
vary testosterone and estradiol in male UHR subjects and found
lower testosterone levels and normal estradiol levels in male UHR
subjects compared with male controls. This suggests potential
neuroendocrine markers for UHR patients. The early effect of
testosterone on neurodevelopment in patients with schizophrenia
was demonstrated in an abnormal ratio between the lengths of
the second and fourth digits (2D:4D ratio; Collinson et al., 2010).
The ratio is a marker of the amount of prenatal circulating testos-
terone and represents early organizational effects of testosterone
on brain development (Lutchmaya et al., 2004). Taken together,
these findings suggest that gonadal hormones protect against the
symptoms of schizophrenia. More than a century ago, Kraepelin
first proposed that “dementia praecox” may be due to an imbal-
ance of sexual hormones (Kendler and Jablensky, 2011). Based on
previous studies, we suggest that vulnerability to psychosis may
reflect an imbalance in sexual hormones rather than a deficiency
in a single hormone. Specifically, aberrant sex hormones, particu-
larly during adolescence and early adulthood, may affect structural
brain abnormalities.
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Structural brain abnormalities in psychosis can be associated
with deficits in lipid membrane and essential fatty acids. Pre-
vious studies have shown abnormalities in membrane function,
including the metabolism and structure of membrane phospho-
lipids involving PUFAs in psychosis. These have been implicated
in the membrane hypothesis of schizophrenia (Horrobin et al.,
1994; Mossaheb et al., 2012). Specifically, mitochondrial dysfunc-
tion due to irregular cellular metabolism and oxidative processes
(Clay et al., 2011) and redox/glutathione dysregulation as a result
of oxidative stress from dysregulation of glutathione synthesis
have been reported (Bokkon and Antal, 2011). The long-chain
PUFAs, such as the omega-3 fatty acids, eicosapentaenoic (EPA)
and docosahexaenoic (DHA) acids, and the omega-6 fatty acids
such as arachidonic acid (AA), are structural components of neu-
ronal membranes. They play a crucial role in brain function
as well as normal growth and development including neuronal
growth, dendritic arborization, and synapse formation (Kawakita
et al., 2006). Thus, consumption of omega-3 PUFAs may influ-
ence brain morphology. Long-chain omega-3 fatty acid intake
in healthy adults has been associated positively with corticol-
imbic GMV in the subgenual ACC, hippocampus, and amyg-
dala (Conklin et al., 2007). However, a recent meta-analysis has
clearly indicated PUFA treatment are not effective in schizophre-
nia (Fusar-Poli and Berger, 2012). Conversely, in UHR patients, a
12-week intervention with omega-3 significantly reduced the tran-
sition rate to psychosis (22.6%) compared with the placebo group.
Moreover, the treatment resulted in significant symptomatic and
functional improvements during the entire 12-month follow-up
period (Amminger et al., 2010). Future studies should investigate
the relationship between omega-3 PUFAs and structural GMV
with respect to preventing the onset of psychosis in UHR patients.
The contribution of membrane turnover in the prediction
of psychosis may also involve using 31P-magnetic resonance
spectroscopy (MRS) to measure the phosphomonoesters and
phosphodiesters levels that are reflective of membrane phospho-
lipid precursors and breakdown products (Reddy and Keshavan,
2003). The relationship between cerebral morphology and mem-
brane phospholipid metabolism, as measured by phosphorus-
MRS (31P-MRS), was reported in patients with schizophrenia
(Keshavan et al., 1993). Patients with schizophrenia showed
altered metabolism of membrane phospholipids during the early
course of the illness, which is consistent with a neurodevelop-
mental abnormality around the critical period of adolescence
(Stanley, 2002). Proton-MRS (1H-MRS) has also been used to
measure metabolite concentrations, such as choline, creatine, N-
acetylaspartate (NAA), glutamine, and glutamate in the brain.
In patients at UHR, 1H-MRS studies showed normal levels of
NAA, a marker of neuronal/axonal integrity, in the hippocampus
of UHR subjects (Wood et al., 2003, 2010). UHR subjects had
metabolic changes in the PFC and ACC that were investigated
using NAA/creatine and NAA/choline ratios (Wood et al., 2003;
Byun et al., 2009). Based on growing evidence for the involvement
of glutamatergic abnormalities in schizophrenia, 1H-MRS studies
in patients with UHR investigated glutamate levels in the brain.
Glutamatergic dysfunction may have an impact on dopaminergic
transmission and ultimately lead to the onset of psychosis. Studies
have shown an altered relationship between glutamate levels and
striatal dopamine function in UHR patients (Stone et al., 2010).
Multimodal studies combining MRI and MRS in UHR subjects
indicated that glutamatergic dysfunction in the thalamus is asso-
ciated with a reduction in GMV in the medial temporal cortex and
insula (Stone et al., 2009). Thus, imbalanced neurochemicals may
underlie structural brain abnormalities in psychosis.
Structural GM abnormalities may be associated with N -
methyl-d-aspartate (NMDA) receptor hypofunction, termed the
excitotoxic hypothesis of psychosis-induced apoptosis (Farber,
2003). According to this hypothesis, disinhibited excitation of
NMDA receptors on gamma-aminobutyric acid (GABA)-ergic
interneurons results in excessive stimulation of the class of glu-
tamate receptors and excitotoxicity, including the generation of
ROS and apoptotic cell death in hippocampal and cortical areas
(Farber, 2003). The involvement of NMDA receptor hypofunction
in schizophrenic pathophysiology has been supported by find-
ings that non-competitive NMDA receptor antagonists, phency-
clidine (PCP), or ketamine, produce schizophrenia-like symptoms
in healthy individuals and profoundly exacerbate pre-existing
symptoms in patients with psychosis.
Taken together, these findings suggest that excessive oxidative
stress and deficits in the ability to cope with oxidative stress as
a result of genetic, epigenetic, and environmental risk factors
may result in structural GM abnormalities. Thus, neuroprotective
strategies may be used as potential treatments to delay or prevent
the progression of the disorder in UHR patients and halt pro-
gressive atrophy in patients with psychosis. In this regard, the use
of recombinant human erythropoietin (EPO), a neuroprotective
hormone (Brines and Cerami, 2005), may improve neuroplastic-
ity (Adamcio et al., 2008) and delay the loss of GMV (Wüstenberg
et al., 2011). More recently, low-dose lithium has been shown to
have neuroprotective effects on hippocampal microstructure in a
small UHR group in a longitudinal MRI–MRS study (Berger et al.,
2012).
Considering ethical issues related to drug intervention in sub-
jects at UHR, an interesting option is to target nutrition. Nutrition
affects the brain throughout life (Bourre, 2006a,b; Dauncey, 2009).
Early nutrition affects brain structures and cognitive function in
later life (Isaacs et al., 2008). A recent VBM study investigated
whether breakfast foods (i.e., bread vs. rice) affect GMV and cog-
nitive function in healthy children (Taki et al., 2010). The rice
group showed higher IQ scores and greater GMV in the STG, infe-
rior frontal gyrus, and caudate nuclei, whereas the bread group
displayed greater GMV in the fronto-parietal region. The authors
speculated that a possible mechanism might be the difference in
the glycemic index (GI) between the two groups; low GI foods
are associated with less blood-glucose fluctuation compared with
high GI foods.
Long-chain PUFAs and antioxidants protect neurons against
oxidative stress. Antioxidants such as vitamins E, C, and A (beta-
carotene), glutathione, and minerals cannot be synthesized de novo
in humans and are therefore required from dietary sources. PUFAs
play a crucial role in brain functioning, as well as in normal growth
and development. It is important to consider the ratio of omega-
6/omega-3 fatty acids in the diet (Simopoulos, 2002) as well as the
consumption of nutrients that can influence omega-3 status (Berr
et al., 2009). Excessive levels of omega-6 promote the pathogenesis
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of many diseases, including inflammatory and autoimmune dis-
eases, whereas increased levels of omega-3 PUFAs exert suppressive
effects (Simopoulos, 2002). Thus, we suggest that nutritional bal-
ance and nutrient interactions are important for mental health and
brain development. Further studies should focus on nutritional
balance in UHR patients and its relationship with GMV.
POTENTIAL ISSUES AND FUTURE DIRECTIONS
Recent advances in psychiatric research have focused on early
detection and prevention of psychosis (McGorry et al., 2009).
However, MRI-based biomarkers for UHR patients should be tar-
geted to improve the specificity and sensitivity of criteria that are
presently available. Although there have been attempts, to date, the
use of MRI-based biomarkers for individuals with psychosis in a
clinical setting has not been successful.
First, methodological variability may be a source of heterogene-
ity across studies (Fusar-Poli et al., 2008a). For example, different
scanners (i.e., 1.5 or 3 T), different methods of data analysis, and
differences in imaging parameters need to be addressed (Fusar-
Poli et al., 2010b). Because a small sample size limits the power to
detect differences, there is a growing probability that the results of
some studies include false positives. Therefore, multicenter studies
are needed to investigate the key comparison between UHR-P and
UHR-NP.
Second, antipsychotic exposure is a confounding factor. Pre-
vious studies have indicated that antipsychotic treatment in
UHR patients may alter GMV in the frontal and temporal areas
(Smieskova et al., 2009). Atypical antipsychotic treatment may
reverse such alterations (i.e., increased GMV in the inferior frontal
gyrus) and prevent the onset of psychosis (Fusar-Poli et al., 2011b).
Although recent neuroimaging studies have taken into account
the effects of antipsychotics, their effects on the brain cannot
be ignored when investigating patients with chronic schizophre-
nia. Chronic patients generally use antipsychotics. Specifically, the
effects of medication exposure should be taken into consideration
in studies of patients at UHR-P and UHR-NP.
Third, the criteria used to identify UHR subjects differ across
studies. The majority of studies use the Comprehensive Assess-
ment of Symptoms and History (CAARMS; Yung et al., 2005) or
the newly developed and shorter Basel Screening Instrument for
Psychosis (BSIP; Riecher-Rössler et al., 2007). Other employs the
Structured Interview for Prodromal Symptoms (SIPS)/the Scale
of Prodromal Symptoms (SOPS) or the basic symptoms (BS)
approach. Discrepancies in previous findings may result from
differences in trait/state risk factors and BS among UHR individ-
uals for psychosis. However in the recent meta-analysis including
over than 2550 HR subjects, the transition risk was compara-
ble across different inclusion criteria (Fusar-Poli et al., 2012b).
A further problem is that the UHR group is heterogeneous and
typically include both UHR-P and UHR-NP subjects, as well as
patients at different levels of risk for psychosis. UHR groups can
be divided into two groups based on their symptoms or on the
duration of the ARMS status since first presentation. Such divi-
sions might sort patients, respectively, as (i) individuals in the
early prodromal state (EPS) with trait vulnerability based on their
symptoms and (ii) individuals in the late prodromal state (LPS)
with APS and BLIPS (Häfner et al., 1992) or as (i) individuals with
short-term ARMS status (ARMS-ST) and (ii) those with long-term
ARMS status (ARMS-LT) based on the time since first presenta-
tion (McGorry et al., 2009; Smieskova et al., 2012a,b). APS and
BLIPS subjects are closer to transition to psychosis than are sub-
jects in the EPS, including trait subjects. Indeed, the intake criteria
for UHR subjects predicted transition over 6 months in the order
of trait alone <APS <BLIPS (Nelson et al., 2011). Hurlemann
et al. (2008) reported that although both EPS and LPS patients
had reduced hippocampal GMV, the reductions were correlated
with poorer cognitive performance in only the LPS. Koutsouleris
et al. (2009a) also investigated differences in GMV between EPS
and LPS patients and between UHR-P and UHR-NP groups. They
found PFC alterations in UHR-P relative to UHR-NP and controls,
which overlapped with the findings in LPS. Jung et al. (2011) found
significantly reduced cortical thickness in the STG, PFC, ACC, and
parietal area of the group with APS and BLIPS compared with
healthy controls. Koutsouleris et al. (2009b) recently distinguished
between EPS and LPS using GMV differences between groups with
multivariate pattern classification.
A previous study that investigated the differences between
ARMS-ST (higher probability) and ARMS-LT (lower probability)
improved our understanding of early intervention in the context
of a clinical staging model (McGorry et al., 2009). ARMS-ST dis-
played less GMV in the insula compared with ARMS-LT and FEP.
Moreover, these GMV differences were correlated with symptoms
(Smieskova et al., 2012b). A multimodal fMRI-VBM approach
revealed smaller GMV in the temporal gyrus and extending into
the insula in ARMS-ST compared with ARMS-LT. Moreover, a
correlation was noted between the reductions in GM and reduced
activation in the same area of ARMS-LT (Smieskova et al., 2012c).
The authors speculated that the differences between ARMS-ST
and ARMS-LT was related to increased vulnerability-associated
alterations in ARMS-ST and to resilience or protective processes
in ARMS-LT. Further studies should take into account differ-
ent levels of risk for psychosis to clarify vulnerability-related,
disease-related, and resilience biomarkers. It would be interest-
ing to investigate cortical changes associated with the duration of
the ARMS status after first presentation in terms of a progres-
sive neurodevelopmental model of schizophrenia. However, that
study must note whether patients identified as ARMS-LT were
originally non-psychotic (i.e., healthy subjects with false-positive
assessment) or remained non-psychotic through their resilience
or protective processes.
Fourth, subjects who meet UHR criteria can transition to schiz-
ophrenia as well as to other psychiatric disorders including bipolar
disorder. This prevents the development of disease-specific pre-
vention strategies and limits the clinical applicability of ongoing
basic research (Fusar-Poli et al., 2008b). The criteria are able to
identify those at UHR for psychosis but not for schizophrenia.
Separate criteria exist for the diagnosis of bipolar disorder (BAR;
Bechdolf et al., 2012a). Previous MRI findings in UHR subjects are
related to psychosis rather than to schizophrenia. Recent studies
have attempted to distinguish UHR subjects who converted to a
diagnosis of schizophrenia (UHR-SZ) from other UHR subjects
who converted to other disorders. Dazzan et al. (2012) divided
UHR subjects into three groups; UHR-SZ, UHR who converted to
affective psychosis (UHR-AFF), and UHR-NP. Decreased volume
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in the parietal cortex and a trend toward decreases in the mid-
dle temporal and inferior frontal cortices were noted in UHR-SZ
subjects, and smaller superior frontal volumes were noted in UHR-
AFF compared with UHR-NP subjects. Additionally, reduced sub-
callosal cingulate volume was noted in UHR-AFF subjects com-
pared with UHR-SZ subjects. Bechdolf et al. (2012b) investigated
amygdalar, insular, lateral ventricular, and whole-brain volumes in
subjects at UHR, all of whom had developed bipolar I or II disor-
der (UHR-BP) at the time of a follow-up session, compared with
UHR-NP and healthy controls. They found reduced amygdalar
and insular volumes in UHR-BP subjects compared with UHR-
NP subjects and controls. An approach that distinguishes UHR-SZ
subjects from individuals with other psychosis will enable the
development of specific biomarkers to detect and prevent the onset
of schizophrenia. Moreover, a thorough understanding of the neu-
robiological nature of psychiatric diseases, along with knowledge
of common and different structural abnormalities before and after
the onset of different psychotic disorders, is warranted.
Fifth, it is still unclear to what extent state and genetic factors
influence structural brain alterations in patients with psychosis
and, particularly, what shared genetic factors in UHR patients
influence their structural abnormalities. This information will
need to be clarified to improve the feasibility of MRI-based bio-
markers. The findings from previous studies that compared EPS
with LPS may implicate more state-related abnormalities than
do other UHR studies. Few studies have directly compared UHR
and GHR. A recent meta-analysis of VBM studies with GHR and
antipsychotic-naïve FEP revealed reduced GMV in the parahip-
pocampal gyrus and ACC in GHR compared with controls and
decreased volumes in the ACC, precuneus, cerebellum, and STG
in FEP compared with GHR (Fusar-Poli et al., 2012e). The authors
concluded that reductions in GM in the ACC are markers of
genetic liability to psychosis, whereas reductions in the STG and
cerebellum are markers of the onset of the illness. Another voxel-
wise meta-analysis was conducted on VBM studies of subjects at
UHR and GHR (Fusar-Poli et al., 2011b). Compared with controls,
reductions in GM were observed in the parahippocampal gyrus,
STG, insula, and inferior and medial frontal gyri in UHR subjects
and in the parahippocampal gyrus and ACC in GHR subjects.
Direct comparisons between subjects at UHR and GHR showed
that subjects at UHR had less GMV in the ACC and greater GMV
in the parahippocampal gyrus, insula, and STG than did GHR
subjects.
Sixth, there are only a few longitudinal studies on this topic.
Adolescence is a critical period in the development of the human
brain, which is particularly vulnerable to the onset of psychosis at
this time (Gogtay et al., 2011). Developmental changes in GMV
occur at different rates in different brain regions (Sowell et al.,
2003; Gogtay et al., 2004). Pantelis et al. (2010) focused on pro-
gressive changes in GM in the PFC, insula, and STG throughout
the transition to psychosis in longitudinal studies of patients with
UHR, as opposed to inconsistent findings from cross-sectional
comparisons in the same cohorts. Trajectories of brain devel-
opment may be more informative than cross-sectional studies
of structural abnormalities. These studies suggested acceleration
of the normal maturational process in vulnerability to psychosis
(Sun et al., 2009a; Gogtay et al., 2011). Many researchers have
suggested the heritability of dynamic brain changes in normal
individuals and non-affected relatives (Gogtay et al., 2007; Raz-
nahan et al., 2011). If abnormalities in normal development
are potential endophenotypes, the concept of the endopheno-
type in schizophrenia should be redefined (Pantelis et al., 2010).
Future studies should clarify the theory that genes associated
with brain development during adolescence and early adulthood
affect brain abnormalities by accelerating the process of normal
neurodevelopment.
Seventh, the effect of sex on brain abnormalities in subjects
at UHR remains unclear. The prevalence of psychosis is greater
in males throughout most of adulthood, but is equal in males
and females by the end of the risk period (MacDonald and Schulz,
2009). Furthermore, sex hormones influence the onset of psychosis
and the associated brain abnormalities.
Eighth, a variety of structural MRI studies in subjects at UHR
now exist, including single MRI and multi-imaging modalities.
Multiple papers have been published on patients at UHR but it
is unclear how many subjects overlap in the published studies.
Further meta-studies should take into account the direct overlap
between subjects.
Finally, the relationship between structural brain abnormali-
ties and cognitive dysfunction during the transition to psychosis is
unclear. One recent study investigated the relationship between
structure and cognition in UHR patients (Koutsouleris et al.,
2010b). Whereas a relationship between executive function and
insular GMV was noted in healthy controls, impaired executive
function and positive correlations with the cerebellum and neg-
ative correlations with the rectus were noted in UHR subjects. A
relationship between executive function and caudate volume in
UHR subjects has recently been reported (Hannan et al., 2010).
Taken together, these observations indicate that additional lon-
gitudinal multimodal studies with larger samples of drug-naïve
subjects who convert to different psychoses, conducted across
numerous centers and with data from multiple scanners are nec-
essary to address the aforementioned issues. Additionally, the
investigation of different features of cortical areas, including struc-
tural asymmetries, gyrification, and shape will provide optimal
MRI-based biomarkers for psychosis.
CONCLUSION
Over the past generation, MRI studies in prodromal psychosis
have exposed a “smoking gun” with respect to whether there
are brain abnormalities and what brain regions are involved in
the pathophysiology of psychosis. Indeed, MRI studies repre-
sent a marvelous approach that provides new knowledge about
the neurobiological trajectories of the disorder. Structural brain
abnormalities in psychosis occur prior to full-blown symptoms
and progressively worsen over the course of the illness. The dis-
coveries from MRI studies, in combination with evidence from
genetic, neurochemical, and environmental studies, are prompting
a paradigm shift in psychosis research. These data are contributing
to a progressive neurodevelopmental model, i.e., a combined neu-
rodevelopmental and neurodegenerative model (Rapoport and
Gogtay, 2011). Furthermore, MRI studies can confirm the safety
evaluation and effectiveness of new candidate drugs and non-drug
interventions. The identification of regions associated with the
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onset of psychosis may localize targets for treatment interventions.
Recent advances in clinical and neuroimaging techniques suggest
the feasibility of MRI-based biomarkers for early interventions.
Knowledge of metabolic processes that regulate homeostatic bal-
ance in the brain can greatly improve the development of new
drugs that protect against structural brain abnormalities. All of
the hypotheses regarding brain abnormalities associated with the
onset of psychosis may converge into the idea that abnormalities
in specific brain processes of energy metabolism are affected by
genetic and/or environmental factors. In the context of impaired
brain energy metabolism, brain abnormalities and psychosis may
result from an imbalance of neurochemical factors and nutri-
tional status. In this regard, neuroprotective agents can interrupt
structural brain alterations and symptoms of psychosis. Moreover,
nutritional components may affect neuroplasticity. Psychosis vul-
nerability studies that use neuroimaging techniques will help to
bridge the gap between fundamental knowledge of brain abnor-
malities in psychosis and therapeutic implications for treatment
and hence pave the way for new treatment strategies.
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